Table 3C.
Complication rates per patient for FIs of the midface except for the orbital area (MAL, NOSE, PN, MAX, TEMP).
| Implant material | TI | PEEK | PPE | ME | HA(/PLLA) | SI | PMMA | ePTFE | HTR | PRO | GC | PCL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total number of patients | 116 | 54 | 355 | 10 | 3 | 242 | 0 | 397 | 0 | 0 | 44 | 0 |
| Total complication rate [%] | 1 (0.86) | 1 (1.9) | 15 (4.2) | 1 (10) | 0 | 20 (8.3) | 0 | 5 (1.3) | 0 | 0 | 10 (23) | 0 |
| Infection/inflammation [%] | 0 | 0 | 5 (1.4) | 1 (10) | 0 | 8 (3.3) | 0 | 3 (0.76) | 0 | 0 | 0 | 0 |
| Hematoma [%] | 0 | 0 | 0 | 0 | 0 | 2 (0.83) | 0 | 1 (0.25) | 0 | 0 | 1 (2.3) | 0 |
| Persistent pain [%] | 0 | 0 | 0 | 0 | 0 | 1 (0.41) | 0 | 0 | 0 | 0 | 0 | 0 |
| Nerve injury [%] | 0 | 0 | 0 | 0 | 0 | 4 (1.7) | 0 | 1 (0.25) | 0 | 0 | 0 | 0 |
| Wound dehiscence [%] | 0 | 1 (1.9) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Implant exposure [%] | 0 | 0 | 5 (1.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Displacement/extrusion [%] | 1 (0.86) | 0 | 5 (1.4) | 0 | 0 | 5 (2.1) | 0 | 0 | 0 | 0 | 9 (20) | 0 |
| Bone resorption [%] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bone erosion [%] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TI, titanium; PEEK, polyetheretherketone; PPE, polyethylene; ePTFE, expanded polytetrafluorethylene; SI, silicone; ME, mersilene; HA/PLLA, hydroxylapatite/poly-l-lactide; PCL, polycaprolactone; PMMA, polymethylmethacrylate; GC, glass ceramics; PRO, Proplast; ZR, zirconium oxide; HTR, hard tissue replacement; FH, forehead; MF, midface; OF, orbitofrontal; FN, frontonasal; ORB, orbital; NOSE, nose; PN, paranasal; MAX, maxilla; MAN, mandible, MAL, malar; CHIN, chin.
Bold values indicate total numbers.